Patents by Inventor Donald Rogier

Donald Rogier has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Retroviral protease inhibitors
    Publication number: 20080103311
    Abstract: N-heterocyclic moiety containing hydroxyethylamino compounds are effective as retroviral protease inhibitors, and in particular as inhibitors of HIV protease.
    Type: Application
    Filed: December 11, 2007
    Publication date: May 1, 2008
    Applicant: Pharmacia Corporation
    Inventors: John Tally, Daniel Getman, Gary DeCrescenzo, Kathryn Reed, Ko-Chung Lin, John Freskos, Michael Clare, Donald Rogier, Robert Heintz, Michael Vazquez, Richard Mueller
  • Retroviral protease inhibitors
    Publication number: 20060166895
    Abstract: N-heterocyclic moiety containing hydroxyethylamine compounds are effective as retroviral protease inhibitors, and in particular as inhibitors of HIV protease.
    Type: Application
    Filed: January 13, 2006
    Publication date: July 27, 2006
    Applicant: Monsanto Company (now named Pharmacia Corporation, which is a wholly owned subsidiary of Pfizer, Inc
    Inventors: John Talley, Daniel Getman, Gary DeCrescenzo, Kathryn Reed, Ko-Chung Lin, John Freskos, Michael Clare, Donald Rogier, Robert Heintz, Michael Vazquez, Richard Mueller
  • Substituted pyrazolyl benzenesulfonamides for the treatment of inflamation
    Publication number: 20050131050
    Abstract: A class of pyrazolyl benzenesulfonamide compounds is described for use in treating inflammation and inflammation-related disorders.
    Type: Application
    Filed: January 31, 2005
    Publication date: June 16, 2005
    Applicant: G.D. Searle & Co.
    Inventors: John Talley, Thomas Penning, Paul Collins, Donald Rogier, James Malecha, Julie Miyashiro, Stephen Bertenshaw, Ish Khanna, Matthew Graneto, Roland Rogers, Jeffery Carter, Stephen Docter, Stella Yu
  • Substituted benzopyran derivatives for the treatment of inflammation
    Publication number: 20050049252
    Abstract: A class of benzopyran, derivatives is described for use in treating cyclooxygenase-2 mediated disorders. Compounds of particular interest are defined by Formula I? wherein X, A1, A2, A3, A4, R, R?, R1 and R2 are as described in the specification.
    Type: Application
    Filed: August 19, 2004
    Publication date: March 3, 2005
    Applicant: G.D. Searle & Co.
    Inventors: Jeffery Carter, Mark Obukowicz, Balekudru Devadas, John Talley, David Brown, Matthew Graneto, Stephen Bertenshaw, Donald Rogier, Srinivasan Nagarajan, Cathleen Hanau, Susan Hartmann, Cindy Ludwig, Suzanne Metz, Donald Korte
  • Process for preparing prodrugs of benzenesulfonamide-containing COX-2 inhibitors
    Publication number: 20050032851
    Abstract: Prodrugs of COX-2 inhibitors are described as being useful in treating inflammation and inflammation-related disorders.
    Type: Application
    Filed: September 13, 2004
    Publication date: February 10, 2005
    Inventors: John Talley, James Malecha, Stephen Bertenshaw, Matthew Graneto, Jeffery Carter, Jinglin Li, Srinivasan Nagarajan, David Brown, Donald Rogier, Thomas Penning, Ish Khanna, Xiangdong Xu, Richard Weier
  • Dihydrobenzopyrans, dihydrobenzothiopyrans, and tetrahydroquinolines for the treatment of COX-2-mediated disorders
    Publication number: 20050010050
    Abstract: A class of dihydrobenzopyrans, dihydrobenzothiopyrans, tetrahydroquinolines, tetrahydronaphthalenes, and analogs thereof, is described for use in treating cyclooxygenase-2 mediated disorders. Compounds of particular interest are defined by Formula (I) wherein X, A1, A2, A3, A4, R, R?, R1 and R2 are as described in the specification.
    Type: Application
    Filed: August 2, 2004
    Publication date: January 13, 2005
    Applicant: G.D. Searle & Co.
    Inventors: Donald Rogier, Jeffery Carter, John Talley
  • Retroviral protease inhibitors
    Publication number: 20050004230
    Abstract: N-heterocyclic moiety containing hydroxyethylamine compounds are effective as retroviral protease inhibitors, and in particular as inhibitors of HIV protease.
    Type: Application
    Filed: March 5, 2004
    Publication date: January 6, 2005
    Applicant: Monsanto Company (now named Pharmacia Corporation, which is a wholly owned subsidiary of Pfizer, Inc
    Inventors: John Talley, Daniel Getman, Gary DeCrescenzo, Kathryn Reed, Ko-Chung Lin, John Freskos, Michael Clare, Donald Rogier, Robert Heintz, Michael Vazquez, Richard Mueller
  • Dihydrobenzopyrans, dihydrobenzothiopyrans, and tetrahydroquinolines for the treatment of COX-2 mediated disorders
    Patent number: 6822102
    Abstract: A class of dihydrobenzopyrans, dihydrobenzothiopyrans, tetrahydroquinolines, tetrahydronaphthalenes, and analogs thereof, is described for use in treating cyclooxygenase-2 mediated disorders.
    Type: Grant
    Filed: October 15, 2002
    Date of Patent: November 23, 2004
    Assignee: Pharmacia Corporation
    Inventors: Donald Rogier, Jr., Jeffery Carter, John Talley
  • Dihydrobenzopyrans, dihydrobenzothiopyrans, and tetrahydroquinolines for the treatment of cox-2 mediated disorders
    Publication number: 20030232844
    Abstract: A class of dihydrobenzopyrans, dihydrobenzothiopyrans, tetrahydroquinolines, tetraydronaphthalenes, and analogs thereof, is described for use in treating cyclooxygenase-2 mediated disorders. Compounds of particular interest are defined by Formula (I) wherein X, A1, A2, A3, A4, R, R″, R1 and R2 are as described in the specification.
    Type: Application
    Filed: October 15, 2002
    Publication date: December 18, 2003
    Inventors: Donald Rogier Jr, Jeffery Carter, John Talley